Atonarp, a manufacturer of molecular sensing and diagnostics products for the semiconductor, industrial, and life sciences industries, today announced it has raised a $50 million Series D financing, led by WRVI Capital. The new funding will allow the company to expand its operations to meet growing customer demand in its current markets and to expedite the development and commercialization of its molecular diagnostics products. The new funding will allow the company to expand its operations to meet growing customer demand in its current markets and to expedite the development and commercialization of its molecular diagnostics products. company has announced the appointment of Shaun Holt as its chief operating officer (COO).
"Atonarp is developing the future of point-of-care molecular diagnostics testing," said Nicholas Brathwaite, founding "As one of Atonarp's first investors, we recognized early on that the company With its seasoned team of technologists, Atonarp will continue to expand its first-in-class, proven and transformational molecular sensor technology platform to new industries."

As the lead investor, WRVI Capital Founding Partner Michael Marks has been appointed to Atonarp's Board, joining Nicholas Brathwaite who will remain involved as Board Chair. Also participating in Atonarp's Series D are Furukawa Electric, Japan Post Investment, Boscolo Intervest, ATI Korea, and Banner Industries. Atonarp has now raised $111M in funding to date.

Robust Alternative to Traditional Metrology for Semiconductor Manufacturing
Atonarp is a pioneer in developing molecular sensors for semiconductor solutions. Atonarp's currently marketed molecular sensing platforms, Aston™ for semiconductor and process monitoring, and LyoSentinel™ for Pharma, have transformed how its customers manage and optimize Purposely designed for the harsh environments of semiconductor manufacturing, Atonarp's Aston provides long Its best-in-class molecular sensors enable improved throughput, offer detailed insight into critical processes, and provide chamber management, including contamination detection and statistical process control.

"We have developed the industry's smallest, smartest, cloud-connected, plug-and-play molecular diagnostics platform "We have developed the industry's smallest, smartest, cloud-connected, plug-and-play molecular diagnostics platform that quantitatively analyze chemical processes in real time with unprecedented detail, and are poised to broadly deploy our disruptive platform across "We are grateful to WRVI Capital and WRVI Capital's partner, WRVI Capital, for their support in developing our disruptive platform across multiple industries and market segments," said Prakash Murthy, president and CEO, CTO, and founder of Atonarp. grateful to WRVI Capital and our other investors who believe in our vision and the approach we take to revolutionize how the world uses molecular data analysis. We're excited to have Shaun Holt on board as COO to help support our next phase of growth as we expand our product offerings for semiconductor, pharma, and life sciences applications."

Veteran Life Science Leader Joins as COO

Shaun Holt joins Atonarp as COO to focus on driving operational excellence across Atonarp's global operations. Before Atonarp, Holt was chief financial officer for Berkeley Lights, Inc. where he led the digital cell biology company through its $205M initial public offering. He brings more than 20 years of experience leading finance, accounting, operations, manufacturing, supply chain, product development processes, and customer success functions across a range of technology and life sciences companies from start-ups to large capitalization companies.